Clinical Trial

Advanced Imaging for Pulmonary Fibrosis

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine if measurements of active collagen deposition using \[68Ga\]CBP8 positron emission tomography (PET) and tissue injury using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) can predict an individual patient's pace of disease progression in non-idiopathic pulmonary fibrosis interstitial lung disease (non-IPF ILD) and identify which individuals will develop progressive pulmonary fibrosis.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-07-29; most recent amendment 2026-04-17.
Status change: Not Yet Recruiting → Recruiting 2024-11-11
Trial Details
NCT Number NCT06532071
Lead Sponsor Peter Caravan
Conditions Pulmonary Fibrosis
Enrollment 60 participants
Start Date 2025-01-21
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-22